IBREXAFUNGERP vs IBUPROFEN LYSINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
IBREXAFUNGERP vs IBUPROFEN LYSINE: Safety Overview
| Metric | IBREXAFUNGERP | IBUPROFEN LYSINE |
|---|---|---|
| Total FAERS Reports | 129 | 277 |
| Deaths Reported | 6 | 27 |
| Death Rate | 4.7% | 9.7% |
| Hospitalizations | 9 | 110 |
| Average Patient Age | 44.4 yrs | 12.6 yrs |
| % Female Patients | 85.2% | 46.1% |
| FDA Approval Date | Jun 1, 2021 | Apr 13, 2006 |
| Manufacturer | N/A | Recordati Rare Diseases Inc. |
| Route | N/A | INTRAVENOUS |
| Marketing Status | Prescription | Prescription |